Czechia· CZ-0026361
AMBIRIX
A kombinationen (hepatitis a + hepatitis b) product containing hepatitis a virus, inactivated + hepatitis b surface antigen, registered in Czechia by GlaxoSmithKline Biologicals S.A., Rixensart. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- HEPATITIS A VIRUS, INACTIVATED + HEPATITIS B SURFACE ANTIGEN
- Manufacturer
- GlaxoSmithKline Biologicals S.A., Rixensart
- Country
- Czechia (CZ)
- ATC code
- J07BC20
- ATC class
- Kombinationen (Hepatitis A + Hepatitis B)
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BC20
Kombinationen (hepatitis a + hepatitis b), as other registers publish it.
- BelgiumAmbirixGlaxoSmithKline Biologicals
- PolandAmbirixGlaxoSmithKline Biologicals S.A.
- IcelandAmbirixGlaxoSmithKline Biologicals S.A.*
- DenmarkAmbirixGlaxoSmithKline Biologicals S.A.
- FinlandAmbirixGlaxoSmithKline Biologicals S.A.
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac8fad9f-1e83-4283-bc16-bd6d8471259e GET /v1/drugs/ac8fad9f-1e83-4283-bc16-bd6d8471259e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "50X1ML",
"substance": "HEPATITIS A VIRUS, INACTIVATED + HEPATITIS B SURFACE ANTIGEN",
"cz_kod_sukl": "0026361",
"product_type": "IM/BT",
"substance_codes": "13899,14766",
"registration_state": "R",
"registration_number": "EU/1/02/224/005"
}See everything about kombinationen (hepatitis a + hepatitis b).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.